LONDON (Reuters) - Pfizer Inc may come back to bid for British drug company AstraZeneca Plc after its reported 60 billion pound ($101 billion) takeover approach was rejected, since a deal could make sense for the U.S. pharmaceuticals giant as it seeks to build up its cancer franchise. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/SUzgHFtQVlQ/story01.htm
Read More
No comments:
Post a Comment